EACCME Accreditation
The Congress has applied for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME). Attendees will receive a certificate of attendance at the end of the Congress.

Who Should Attend
This online educational activity is specifically designed for hematologists, oncologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved and/or interested in the therapeutic management of patients with hematologic malignancies, including multiple myeloma, chronic lymphocytic leukemia, and Hodgkin's and non-Hodgkin lymphomas.

Objectives
After successful completion of this course, participants should:

• Have increased awareness/knowledge regarding:
  • The evolving role of transplantation in managing hematologic malignancies
  • The changing role of radiation therapy in treating hematologic malignancies
• Have increased confidence in their ability to:
  • Incorporate latest data into treatment plans for newly diagnosed hematologic malignancies
  • Apply novel agents and strategies to treatment of relapsed and/or refractory disease
• Increase the frequency (compared with current level) which with they plan to:
  • Use prognostic tools such as imaging, cytogenetics, and risk stratification to guide treatment decisions for patients with hematologic malignancies
  • Recommend maintenance therapy for appropriate patients with hematologic malignancies
  • Enroll patients with difficult-to-treat hematologic malignancies in clinical trials of novel agents

To Register: You may register online by 16 February 2012, by calling Imedex at +1 (678) 242 0906 or by returning the registration form in this program by mail or fax at +1 (678) 242 0920. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting. To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Payment: To pre-register, registration and payment must be received no later than 16 February 2012. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full.

Registration fees must be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add €50 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the Congress: 8th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice – A279.01. An attendee is not registered until full payment is received.

Wire to: Bank of America, NA London, 1 Alie Street E1ADE London UK, Swift Code: BOFAGB22, Sort Code: 165050 Beneficiary: Bank of America Domestic Deposit #5687, Account #: 600895687029, Reference: Imedex, Inc. Account # 10726-118, IBAN: GB89 BOFA 1650 5095 6870 29.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, Congress materials, processing of certificates of attendance, and all event functions as specified in the agenda.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 16 February 2012. The amount of registration fees remitted, minus a €75 administrative charge, will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be made if notice is received after 16 February 2012.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

Italian Participants
Alijet & Fargo International SRL has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:
Alijet & Fargo International SRL
Via Pietro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078

Novotel Amsterdam City

Europaboulevard 10
1083 AD Amsterdam Netherlands
Tel (+31)20/5411123
Fax (+31)20/6462823
www.NovotelAmsterdamCity.com

Novotel Amsterdam City is located in the heart of Amsterdam's business district, right by the Amsterdam RAI Exhibition and Convention Center and near the WTC. The RAI train station is only a short walk away and offers frequent connections to Amsterdam city center and Schiphol, making the hotel ideal for both business trips and weekend breaks. We have renovated our entire ground floor, and to offer our guests an even better service, we have expanded our meeting, restaurant and fitness facilities.

For the convenience of attendees, a room block with a limited number of rooms has been reserved at the discounted group rate of €139.00 single/double occupancy, inclusive of tax. This limited number of discounted rooms will be available until 3 February 2012. This discounted rate is not guaranteed outside the Congress dates. Reservations received after 3 February 2012 or after the room block has been filled (whichever comes first) are subject to availability and prevailing hotel rates.

To reserve your room please contact the Novotel Amsterdam City reservations department at (+31)20/5411123 or visit the hotel’s website at www.NovotelAmsterdamCity.com. To receive the group rate, callers must identify themselves as being with the 8th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice group.. Reservation requests received after 3 February 2012 may not be guaranteed the group rate.

Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1 (678) 242 0719, or by email at cme@imedex.com.

Information coming soon.

Exhibit space is available to companies interested in participating in this Congress through exhibition. For more information, please contact Imedex at +1 (678) 242 0719 or by email at exhibits@imedex.com.